Trial
NCT00427297
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Washington
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
HIV Infections
Intervention
AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)
Why stopped
There is no longer equipoise. DSMB recommended termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-27